# A Study of LY3463251 in Healthy Participants

> **NCT03764774** · PHASE1 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 118 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3463251
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03764774
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-06
- **Primary completion:** 2020-12-07
- **Final completion:** 2020-12-07
- **Target enrollment:** 118 (ACTUAL)
- **Why stopped:** Trial was terminated due to an insufficient benefit/tolerability ratio
- **Last updated:** 2025-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764774, "A Study of LY3463251 in Healthy Participants". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03764774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*